CME Presentations

Spinal Muscular Atrophy


Presentations


Speakers

  • Mary Schroth, MD

    Mary Schroth, MD

    Mary Schroth, MD

    Chief Medical Officer

    Mary Schroth, MD, is the chief medical officer of Cure SMA. She is professor emeritus at the University of Wisconsin School of Medicine and Public Health in Madison where she served as a pediatric pulmonologist, co-director of the Pediatric Neuromuscular Clinic, and director of the Pediatric Pulmonary Center Grant. Dr Schroth feels honored to be able to share her expertise of SMA care through her role with Cure SMA.
  • Richard Shell, MD

    Richard Shell, MD

    Richard Shell, MD

    Professor of Pediatrics

    Richard Shell, MD, is professor of pediatrics and section chief of the Department of Pulmonary Medicine at Nationwide Children's Hospital at The Ohio State University College of Medicine in Columbus. He plays an active clinical and research role in the care of patients with neuromuscular disease. Dr Shell’s other research interests include asthma and cystic fibrosis, where he assists in many clinical trials within his department. He is a member of the Therapeutic Development Network of the Cystic Fibrosis Foundation and has administrative rolls with both Parent Project Muscular Dystrophy (PPMD) and CureSMA. Dr Shell has been recognized by his patients for excellence in family-centered care. He received his medical degree from the Medical College of Ohio in Toledo.
  • Julie A. Parsons, MD

    Julie A. Parsons, MD

    Julie A. Parsons, MD

    Professor of Clinical Pediatrics and Neurology

    Julie A. Parsons, MD, is a professor of clinical pediatrics and neurology at the University of Colorado School of Medicine in Aurora, the Haberfeld Family Endowed Chair in Pediatric Neuromuscular Disorders, and co-director of the neuromuscular clinic at Children’s Hospital Colorado. Her clinical interests include neuromuscular diseases such as muscular dystrophies, spinal muscular atrophy (SMA), and myotonic dystrophies. She is an active participant and principal investigator for many clinical trials, and is a member of organizations that include the Child Neurology Society and the American Academy of Neurology. Dr Parsons earned her MD from the University of Colorado School of Medicine, followed by residencies in pediatrics and child neurology and a neuromuscular medicine fellowship.
  • Linda Lowes, PT, PhD

    Linda Lowes, PT, PhD

    Linda Lowes, PT, PhD

    Associate Professor, Department of Pediatrics

    Linda P. Lowes, PT, PhD, is associate professor of pediatrics at The Ohio State University and a principal investigator in the Center for Gene Therapy at Nationwide Children’s Hospital in Columbus. Her research interests focus on optimizing functional outcomes in adults and children with neuromuscular disorders. Dr Lowes is also interested in promoting clinical trial readiness through data to drive outcome measure selection. To facilitate clinical trial readiness, she has conducted numerous natural history studies in limb-girdle muscular dystrophies and other disorders. Dr Lowes was recently elected to the executive board for TreatNMD and awarded the Excellence in Innovation award.

CME Information

Post-Gene Replacement Treatment SMA Phenotypes and Multidisciplinary Care


PIM LogoPQH Logo

LEARNING OBJECTIVES

At the conclusion of this activity, participants will be able to:

  • Describe the evolution of SMA phenotypes that may be associated with gene replacement therapy in patients with SMA
  • Identify best practices for multidisciplinary post-treatment management of patients with SMA who have received gene replacement therapy
Jointly provided by Postgraduate Institute for Medicine and PlatformQ Health Education, LLC.

ACKNOWLEDGEMENT

This activity is supported by an educational grant from AveXis.

TUITION

Complimentary

JointlyAccreditedProvider Logo

JOINT ACCREDITATION STATEMENT

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and PlatformQ Health Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

LIVE CREDIT DESIGNATION STATEMENTS

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 1 contact hours.

ENDURING CREDIT DESIGNATION STATEMENTS

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 1 contact hours.

DATE OF RELEASE/EXPIRATION

Live Activity

Monday, July 13, 2020 from 12:00pm – 1:00pm ET

Enduring Material

The enduring material will be available from July 13, 2020 - July 13, 2021.

TARGET AUDIENCE

Pediatric neurologists, neurologists, pediatricians, neuromuscular specialists, pulmonologists, pediatric gastroenterologists, advanced practice (NPs, PAs), physical therapists/occupational therapists, nutritionists, geneticists and genetic counselors, and other healthcare professionals involved in the care of patients with SMA.

ESTIMATED TIME TO COMPLETE

This activity consists of 1 session which should take approximately 1 hour to complete.

METHOD OF PARTICIPATION

There are no fees to participate in this activity. To participate in the activity, go to www.NeuroSeriesLive.com. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a minimum score of 70% on the post-test.

HARDWARE/SOFTWARE REQUIREMENTS

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

DISCLOSURE OF CONFLICTS OF INTEREST

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Faculty or Presenter Reported Financial Relationship
Julie Parsons, MD Consulting Fees: AveXis, Biogen
Contracted Research: AveXis, Biogen, Scholar Rock
Richard Shell, MD Consulting Fees: AveXis, Biogen
Linda Lowes, PT, PhD Consulting Fees: AveXis (advisory board)
Mary Schroth, MD Consulting Fees: Audentes

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Faculty or Presenter Reported Financial Relationship
Carole Drexel
Medical Director
PlatformQ Health Education, LLC
None

The PIM planners and managers have nothing to disclose.

The following PlatformQ Health Education, LLC planner, Kim Jacobson, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

DISCLOSURE OF UNAPPROVED/OFF LABEL USE (if applicable):

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

CONTACT INFORMATION

Accreditation Support:
Please contact the Postgraduate Institute for Medicine at www.pimed.com.

Technical Support:
For any technical issues or issues with your CME Certificate, please contact NeuroSeriesLive at 877-394-1306 or at Support@NeuroSeriesLive.com.

Advances in Spinal Muscular Atrophy Management


LEARNING OBJECTIVES

At the conclusion of this activity, participants will be able to:

  • Conduct a thorough clinical examination and genetic testing for the early and accurate diagnosis of SMA
  • Evaluate safety and efficacy data of recently available disease-modifying treatment and supportive strategies for SMA
  • Summarize the therapeutic strategies of emerging agents for SMA based on improved understanding of SMA pathophysiology

Acknowledgement

This activity is supported by an educational grant from Biogen.

Tuition

Complimentary

Accreditation Statement

The activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Albert Einstein College of Medicine and PlatformQ Health Education, LLC. Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statements

Live Internet Activity

Albert Einstein College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Enduring Material

Albert Einstein College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Credits

The American Academy of Nurse Practitioners (AANP) and American Nurses Credentialing Center (ANCC) accept AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.

Date of Release/Expiration

Live Internet Activity
February 13, 2019 from 2:00 PM ET – 3:00 PM ET.

Enduring Material
The enduring material will be available from February 13, 2019 to February 13, 2020.

Intended Audience

This activity is intended for pediatric neurologists, neurologists, pediatricians, primary care physicians, internal medicine physicians, advanced practice clinicians, physical therapists, occupational therapists, and health care providers who encounter and manage patients with SMA.

Estimated Time to Complete

This activity consists of one session, which should take approximately 1 hour to complete.

Method of Participation

There are no fees to participate in this activity. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the posttest and activity evaluation. It is estimated that this module will take approximately 1 hour to complete. To receive AMA PRA Category 1 Credits™, participants must receive a minimum score of 70% on the posttest.

Hardware/Software Requirements

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

Faculty Disclosure

The "Conflict of Interest Disclosure Policy" of Albert Einstein College of Medicine requires that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience any relationship(s) with a pharmaceutical or equipment company. Any presenter whose disclosed relationships prove to create a conflict of interest, with regard to their contribution to the activity, will not be permitted to present.

The Albert Einstein College of Medicine also requires that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience when discussing any unlabeled or investigational use of any commercial product, or device, not yet approved for use in the United States.

Presenter

Nancy L. Kuntz, MD
Fees for Non-CME/CE Services: Biogen (Lectured in Australia and Japan relating to use of nusinersen in SMA patients, particularly those with advanced scoliosis and respiratory weakness, prepared own slides)
Contracted Research: Audentes, AveXis, Biogen, Cytokinetics, Pfizer, Roche, Sarepta
Medical Advisory Boards: Audentes, AveXis, Biogen, Roche, Sarepta
Will reference the following unlabeled/unapproved drugs: Risdaplan and AveXis-101

Julie Parsons, MD
Consulting Fee: AveXis, Biogen, Roche
Contracted Research: PI for AveXis, Biogen, Cytokinetics, Scholar Rock
Will reference the following unlabeled/unapproved drugs: Risdaplan and AveXis-101

Peer Reviewer

David Kaufman, MD
Has nothing to disclose relevant to this activity

Providers

Einstein-Montefiore Center for Continuing Medical Education
The Center for Continuing Medical Education (CCME) staff at Albert Einstein College of Medicine has no disclosures to report relevant to this activity.

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

PlatformQ Health Education, LLC

David Howard
Medical Director

Has nothing to disclose relevant to this activity.

Elizabeth del Nido
Program Manager

Has nothing to disclose relevant to this activity.

Discalimers (if applicable)

The material is prepared based on a review of multiple sources of information but is not exhaustive of the subject matter. Therefore, health care professionals and other individuals should review and consider other publications and materials about the subject matter other than relying solely on the information contained in this material.

The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by Albert Einstein College of Medicine, NeuroSeriesLive, PlatformQ Health Education, LLC or the program grantor. Reasonable efforts have been made to present educational subject matter in a balanced, unbiased fashion and in compliance with regulatory requirements. Each participant must use his/her personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

Contact Information

Accreditation Support:
Please send all inquiries to: Montefiore Medical Center, CCME, 3301 Bainbridge Avenue, Bronx, New York 10467, or via phone at (718) 920-6674, or via fax to (718) 798-2336, or via email to cme@montefiore.org.

Technical Support:
For any technical issues or issues with your CME Certificate, please contact OMedLive at (877) 394-1306 or at Support@NeuroSeriesLive.com